MIAMI, July 17, 2019 (GLOBE NEWSWIRE) — PreCheck Health Services, Inc. (“PreCheck” or the “Company”) (OTC: HLTY), an issuer of medical screening devices that give facts to assist physicians in preventing and treating continual illnesses, introduced nowadays that the Company has entered right into a buy agreement with Justin and Stacey Anderson to collect JAS Practice Management, Inc. Dba JAS Consulting, Inc. And Center for Psychological Development, Inc., dba CPD Integrated Health Care. Mr. Anderson is the Company’s chief working officer and a director.
JAS Consulting is a complete-carrier billing employer that offers healthcare practice management, billing, and coding services to various medical specialties to maximize exercise efficiency and decrease costs. CPD Integrated Health Care offers outpatient behavioral fitness services and number-one care in seven medical clinics in Texas and Oklahoma.
“Both acquisitions bless PreCheck and illustrate our shareholder dedication,” stated Mr. Lawrence Biggs, Chief Executive Officer of PreCheck Health Services, Inc. “We agree that the billing and processing supplied using JAS Consulting will be key elements to our success, as they permit us to provide greater green services to our potential client base of medical doctors and scientific practices. Furthermore, CPD’s seven scientific clinics will allow us to check extra medical screening devices before deploying nationally. We are confident these traits can position the Company on a trajectory for multiplied increase and growth and might be at once accretive for our buyers.”
“Upon the close of these acquisitions, all of our administrative offerings will be streamlined via being included beneath the PreCheck umbrella,” stated Mr. Justin Anderson, Chief Operating Officer of PreCheck, and “I sit up for the growth opportunities this acquisition will provide, as both JAS Consulting and CPD Integrated Healthcare provide platforms through which the today’s advances in medical technology can be examined and validated before moving into the market.”
The settlement terms encompass 5 million convertible preferred stocks that convert to five million shares of common stock upon the stock buying and selling at $2 in keeping with proportion. Also, PreCheck pays a $1 million coin consideration at closing. Further information on the terms of this agreement is in the Company’s regulatory filing, which may be accessed at www.Sec.Gov.
About PreCheck Health Services, Inc.
PreCheck’s present-day commercial enterprise distributes a medical screening device, the PC8B, which it purchases from the producer under a non-public label agreement. A PC8B clinical tool is a screening tool designed for use by icons and scientific personnel to deal with an affected person’s health. The device displays sufferers for biomarkers that are pre-cursors to certain diseases.
The PC8B is designed to allow the health practitioner to determine the indicators of more than one patient’s fitness issue being screened. The result of the screening is that the PC8B allows physicians to view statistics regarding positive biomarkers immediately after the screening, which may help them prevent chronic illnesses, such as diabetes and cardiovascular disorders. The PC8B is noninvasive and, combined with its ankle-brachial index test, takes less than 8 minutes to finish an evaluation.
Disclaimer for Forward-Looking Information
Certain statements contained in this press release, including, without limitation, statements containing the words “believes,” “anticipates,” “expects,” and phrases of similar import, constitute “ahead-looking statements” inside the which means of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown dangers and uncertainties.
The Company’s actual effects might also differ materially from those predicted in its forward-looking statements because of several things, including our capability to obtain enormous investment required for our operations, our ability to raise the coins part of the purchase rate for the acquisition of JAS Consulting and CPD Integrated Health Care, our ability to market our product to physicians, our ability to generate a gross margin from any income we might also make; our dependence upon a sole provider for our products and our reliance of the dealer to protect its highbrow belongings included in our product; our potential to gain rights to and to marketplace successfully marketplace products including the PC8B, following the purchase of JAS Consulting and CPD Integrated Health Care, our capacity to broaden the business of these agencies.
Our capacity to conform with relevant laws regarding the operation of a medical exercise, along with legal guidelines referring to the corporate exercise of medicine and the financial courting among PreCheck and the scientific practices it owns; our capability to cope with the dangers related to the operation of a clinical practice, which includes claims relating to malpractice; as well as different dangers contained in “Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” inside the Company’s Form 10-K for the year ended December 31, 2018, and in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in its Form 10-Q for the quarter ended March 31, 2019, and any facts contained in every other filing we make with the SEC.
